POLE and colorectal cancer: More recently, this group further investigated the longitudinal properties of neoantigen presentation by 45 colorectal cancer cell lines—including POLE-mutated, MSI-high, and microsatellite-stable examples propagated both in vitro (cell culture) and in vivo (xenografts)—and by patient-derived xenografts.